More about
Congenital Pomc Deficiency
News
December 24, 2024
2 min read
Save
FDA expands setmelanotide approval for rare forms of obesity to children aged 2 to 5 years
The FDA approved an expanded indication for setmelanotide to include children aged 2 to 5 years with several genetic forms of obesity, Rhythm Pharmaceuticals announced.